How much does a box of Acemini cost?

Aximini, this miraculous drug known as the third-generation tyrosine kinase inhibitor (TKI), is gradually emerging in the treatment of chronic myelogenous leukemia (CML). Compared with early TKI drugs, aceminib is unique in that it can act on ABL1kinase through "myristoyl span>" pocket, this innovative mechanism allows it to show higher efficacy against some common TKI resistance mutations, especially the T315I mutation.

Aximinib can precisely block the proliferation of leukemia cells and has demonstrated impressive efficacy and tolerability in patients who have failed to respond to previous generations of TKI drugs. Therefore, it has become a new hope for CML patients, especially drug-resistant patients.

However, for patients, the price of drugs is always a focus. Unfortunately, Aceminib is not currently available in mainland China, and patients cannot purchase the drug directly through domestic pharmacies or hospitals. If patients need to use Asiminib, they can only purchase it through overseas channels.

In the international market, Asiminib’s original drug is mainly produced by European pharmaceutical companies, and its price is relatively high, usually around tens of thousands of yuan per box. This price is undoubtedly a heavy financial burden for many patients. However, with the rise of generic drugs, patients have more affordable options. Generic drugs produced in Laos are one of the options currently attracting much attention. The price is relatively cheap, only about more than 4,000 yuan per box.

Although the price of generic drugs is low, their pharmaceutical ingredients are basically the same as those of the original drugs, and their therapeutic effects and safety have also reached a similar level. Therefore, for patients with limited financial conditions, generic drugs in Laos are undoubtedly a cost-effective choice.